How many institutions own BJDX stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own BJDX shares is 6, representing 7.09% of the company's common stock.

Who are the major shareholders selling Bluejay Diagnostics, Inc. stock?

UBS GROUP AG, in the last quarter, reduced its stake in BJDX by -100% restricting it's holding to 0 shares of worth nearly -. ADVISOR GROUP HOLDINGS, INC. also lessened -100% of the BJDX shares from its portfolio, reducing its holding to 0 shares of worth -. WELLS FARGO & COMPANY/MN also shunned BJDX shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying BJDX stock?

As per its latest 13F filing, N/A increased its stake in BJDX by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of BJDX to its portfolio, raising its holding to - shares of worth -. N/A also increased its BJDX shares holding by N/A which brought its holding to - shares worth -.

BJDX's major insiders: who are they?

The insider with the most stakes in BJDX is Wurth Douglas Clark , at the company. Additionally, BJDX stock is highly held by Chief Financial Officer Fisher Kenneth R and President and CEO Dey Indranil among others.

Did an insider recently sell BJDX stock?

Company executives, directors, and other insiders own 0.26% percent of Bluejay Diagnostics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which BJDX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased BJDX stock?

There have been 0 transaction(s) during the past 6-months in which Bluejay Diagnostics, Inc. insiders have bought stock, totalling 0 shares

How much of BJDX does insiders own?

Around 0 Bluejay Diagnostics, Inc. shares are held by insiders, which represents about 0.26% of BJDX stock.

Who is the insider with the largest stake?

BJDX , Wurth Douglas Clark holds the largest portfolio of the company's shares. BJDX shares owned by Wurth total nearly 2.29 million.

Which institution holds the most shares in BJDX?

COPPELL ADVISORY SOLUTIONS LLC is the largest institutional owner in BJDX which holds 12 shares worth $674.00 or 0.02% of the total BJDX shares outstanding followed by UBS GROUP AG with ownership of 0 shares representing 0% of the BJDX ownership. ADVISOR GROUP HOLDINGS, INC. is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Is Bluejay Diagnostics, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the BJDX is concerned, it is a stock which is not optionable.

Is there a short position on BJDX's shares?

Number of BJDX shares short is 106.40K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding BJDX shares are there?

As of today, 1.49M shares of BJDX are outstanding.

Is there many float in BJDX stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, BJDX has 1.03M shares in float.

BJDX short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for BJDX is 0.02.

Stock Ideas

BJDX Stock Ownership Breakdown

NASDAQ : BJDX

Bluejay Diagnostics

$1.96

-0.05-2.49%

At Close 4:00 PM

65.13

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares7.12

Short Percent Of Float7.13

Shares Outstanding1.49M

Shares Float1.03M

Shares Short106.40K

Short Ratio0.02

7.13%

Short % of Float

7.12%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

0.26% Percentage of Shares held by All Insiders

7.09% Percentage of Shares held by All Institutions

7.11% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 7.09% of BJDX shares are held by financial institutions. COPPELL ADVISORY SOLUTIONS LLC is the top corporate investor, holding 12 shares valued at $674.00. A 0.02% stake in Bluejay Diagnostics, Inc. is owned by the company. UBS GROUP AG owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Sep 30, 2023	COPPELL ADVISORY SOLUTIONS LLC	0.02%	12	674	0	0
Sep 30, 2023	UBS GROUP AG	0%	0	-	-5.16K	-100.00%
Sep 30, 2023	ADVISOR GROUP HOLDINGS, INC.	0%	0	-	-500	-100.00%
Sep 30, 2023	WELLS FARGO & COMPANY/MN	0%	0	-	-74	-100.00%
Sep 30, 2023	NORTHERN TRUST CORP	0%	0	-	-11.7K	-100.00%
Sep 30, 2023	VANGUARD GROUP INC	0%	0	-	-15.9K	-100.00%
Sep 30, 2023	RENAISSANCE TECHNOLOGIES LLC	0%	0	-	-49.1K	-100.00%
Sep 30, 2023	GEODE CAPITAL MANAGEMENT, LLC	0%	0	-	-29.14K	-100.00%
Sep 30, 2023	TWO SIGMA SECURITIES, LLC	0%	0	-	-27.09K	-100.00%
Sep 30, 2023	HRT FINANCIAL LP	0%	0	-	-29.91K	-100.00%
Sep 30, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-10.13K	-100.00%

Insiders

Among the BJDX insiders holding of 0.26% of the stake in company, WURTH DOUGLAS CLARK, , holds the largest shares of 2.29M. FISHER KENNETH R, Chief Financial Officer, is the second largest BJDX insider with ownership of 40K shares. DEY INDRANIL, President and CEO, stands third with possession of 28.53K shares of that stake.

Insiders	Designation	Shares Held
WURTH DOUGLAS CLARK		2.29M
FISHER KENNETH R	Chief Financial Officer	40K
DEY INDRANIL	President and CEO	28.53K
KINDER GORDON WINSTON	Chief Financial Officer	18.5K
DEY SVETLANA	director	1.5K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Dec 13, 2023	DEY SVETLANA	PURCHASE	3.07	500	1.54K	1.5K
Dec 13, 2023	DEY INDRANIL	PURCHASE	3.27	500	1.64K	28.53K
Mar 28, 2023	DEY INDRANIL	PURCHASE	0.44	2K	880	660.54K
Mar 27, 2023	DEY INDRANIL	PURCHASE	0.44	8K	3.52K	558.54K
Mar 24, 2023	DEY SVETLANA	PURCHASE	0.44	10K	4.4K	47.5K
Aug 26, 2022	FISHER KENNETH R	PURCHASE	1.03	20K	20.6K	40K
Apr 25, 2022	FISHER KENNETH R	PURCHASE	0.99	20K	19.8K	20K
Mar 17, 2022	DEY SVETLANA	PURCHASE	1.18	10K	11.83K	10K
Mar 17, 2022	KINDER GORDON WINSTON	PURCHASE	1.16	2.5K	2.9K	18.5K
Mar 17, 2022	WURTH DOUGLAS CLARK	PURCHASE	1.18	40K	47.12K	2.29M
Mar 16, 2022	WURTH DOUGLAS CLARK	PURCHASE	1.09	60K	65.4K	2.25M
Mar 14, 2022	KINDER GORDON WINSTON	PURCHASE	1.02	5K	5.1K	16K

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.